Apolipoprotein E allele frequencies in sporadic inclusion body myositis

Muscle and Nerve

Volumn 19, Issue 12, 1996, Pages 1605-1607

  Love, Seth ^a   Nicoll, James A R ^b   Lowe, James ^c   Sherriff, Fiona ^d  

^a FRENCHAY HOSPITAL   (United Kingdom)

^b SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Alzheimer's disease; amyloid; apolipoprotein E; inclusion body myositis; inflammatory myopathy

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ARTICLE; CELL INCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; HUMAN; HUMAN TISSUE; INCLUSION BODY MYOSITIS; MALE; MUSCLE BIOPSY; MYOSITIS; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; APOLIPOPROTEINS E; FEMALE; GENE FREQUENCY; HUMANS; MALE; MIDDLE AGED; MYOSITIS, INCLUSION BODY;

EID: 0029829393     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4598(199612)19:12<1605::AID-MUS11>3.0.CO;2-Q     Document Type: Article

References (32)

1. Amouyel P, Vidal O, Launay JM, Laplanche JL: The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. Lancet 1994;344:1315-1318.
2. Askansas V, Alvarez RB, Engel WK: β-amyloid precursor epitopes in muscle fibers of inclusion-body myositis. Ann Neurol 1993;34:551-560.
3. Askansas V, Engel WR New advances in inclusion-body myositis. Curr Opin Rheumatol 1993;5:732-741.
4. Askansas V, Engel WK, Alvarez RB: Light and electron microscopic localisation of β-amyloid protein in muscle biopsies of patients with inclusion-body myositis. Am J Pathol 1992;141: 31-36.
5. Baumbach LL, Neville HE, Ringel SP, Garcia C, Sujansky E: Familial inclusion body myositis: evidence for autosomal dominant inheritance. Am J Hum Genet 1990;47(suppl):A48.
6. Castano EM, Prelli F, Wisniewski T, Golabek A, Kumar RA, Soto C, Frangione B: Fibrillogenesis in Alzheimer's disease of amyloid β peptides and apolipoprotein E. Biochem J 1995;306: 599-604.
7. Cataldo AM, Hamilton DJ, Nixon RA: Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer's disease. Brain Res 1994;640:68-80.
8. Cataldo AM, Nixon RA: Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brains. Proc Natl Acad Sci USA 1990;87:3861-3865.
9. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC Jr, Rimmler JB, Locke PA, Conneally PM, Schmader KE, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genet 1994;7:180-184.
10. Garlepp MJ, Tabarias H, van Bockxmeer FM, Zilko PJ, Laing B, Mastaglia FL: Apolipoprotein E ε4 in inclusion body myositis. Ann Neurol 1995;38:957-959.
11. Greenberg SM, Rebeck GW, Vonsattel JPG, Gomez Isla T, Hyman BT: Apolipoprotein ε4 and cerebral haemorrhage associated with amyloid angiopathy. Ann Neurol 1995;38: 254-259.
12. Harrington CR, Anderson JR, Chan KK: Apolipoprotein E type ε4 allele frequency is not increased in patients with sporadic inclusion-body myositis. Neurosci Lett 1995;183:35-38.
13. Harrington CR, Louwagie J, Rossau R, Vanmechelen E, Perry RH, Perry EK, Xuereb JH, Roth M, Wischik CM: Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. Am J Pathol 1994;145:1472-1484.
14. Hyman BT, West HL, Rebeck GW, Buldyrev SV, Mantegna RN, Ukleja M, Havlin S, Stanley HE: Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome). Proc Natl Acad Sci USA 1995;92: 3586-3590.
15. Ladu MJ, Falduto MT, Manelli AM, Reardon CA, Getz GS, Frail DE: Isoform-specific binding of apolipoprotein E to β-amyloid. J Biol Chem 1994;269:23403-23406.
16. Massa R, Weller B, Karpati G, Shoubridge E, Carpenter S: Familial inclusion body myositis among Kurdish-Iranian Jews. Arch Neurol 1991;48:519-522.
17. Mendell JR, Sahenk Z, Gales T, Paul L: Amyloid filaments in inclusion-body myositis. Arch Neurol 1991;48:1229-1234.
18. Murakami N, Ihara Y, Nonaka I: Muscle fiber degeneration in distal myopathy with rimmed vacuole formation. Acta Neuropathol 1995;89:29-34.
19. Namba Y, Tomonawa M, Kawasaki H, Otomo E, Ikeda K: Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 1991;541:163-166.
20. Nicoll JAR, Love S, Kinrade E: Distribution of herpes simplex virus DNA in the brains of human long-term survivors of encephalitis. Neurosci Lett 1993;157:215-218.
21. Nicoll JAR, Roberts GW, Graham DI: Apolipoprotein E ε4 allele is associated with deposition of amyloid β-protein following head injury. Nature Med 1995;1:135-137.
22. Pickering-Brown SM, Mann DMA, Owen F, Ironside JW, De Silva R, Roberts DA, Balderson DJ, Cooper PN: Allelic variations in apolipoprotein E and prion protein genotype related to plaque formation and age of onset in sporadic Creutzfeldt-Jakob disease. Neurosci Lett 1995;187:127-129.
23. Sanan DA, Weisgraber KH, Russell SJ, Mahley RW, Huang D, Saunders A, Schmechel D, Wisniewski T, Frangione B, Roses AD, Strittmatter WJ: Apolipoprotein E associates with β-amyloid peptide of Alzheimer's disease to form novel monofibrils: isoform apoE4 associates more efficiently than apoE3. J Clin Invest 1994;94:860-869.
24. Sarkozi E, Askansas V, Johnson SA, Engel WK, Alvarez RB: β-amyloid precursor protein mRNA is increased in inclusion-body myositis muscle. NeuroReport 1993;4:815-818.
25. Saunders AM, Schmader K, Breitner JCS, Benson MD, Brown WT, Goldfarb L, Goldgaber D, Manwaring MG, Szymanski MH, McCown N, Dole KC, Schmechel DE, Strittmatter WJ, Pericak-Vance MA, Roses AD: Apolipoprotein E ε4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 1993;342:710-711.
26. Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD: Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993;90:9649-9653.
27. Sherriff FE, Joachim CL, Squier MV, Esiri MM: Ubiquitinated inclusions in inclusion-body myositis patients are immunoreactive for cathepsin D but not β-amyloid. Neurosci Lett 1995; 194:37-40.
28. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD: Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;192:1977-1981.
29. Talbot C, Lendon C, Craddock N, Shears S, Morris JC, Goate A: Protection against Alzheimer's disease with apoE ε2. lancet 1994;343:1432-1433.
30. Villanova M, Kawai M, Lübke U, Oh SH, Perry G, Six J, Ceuterick C, Martin J-J, Cras P: Rimmed vacuoles of inclusion-body myositis and oculopharyngeal muscular dystrophy contain amyloid precursor protein and lysosomal markers. Brain Res 1993;603:343-347.
31. Wenham PR, Price WH, Blundell G: Apolipoprotein E genotyping by one-stage PCR. Lancet 1991;337:1158-1159.
32. Wisniewski T, Frangione B: Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 1992;135:235-238.